- Home
- SFWL vs ANIX Comparison
SFWL vs ANIX Comparison
Compare SFWL & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- ANIX
- Stock Information
- Founded
- SFWL 2001
- ANIX 1982
- Country
- SFWL China
- ANIX United States
- Employees
- SFWL N/A
- ANIX N/A
- Industry
- SFWL Trucking Freight/Courier Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- SFWL Industrials
- ANIX Health Care
- Exchange
- SFWL Nasdaq
- ANIX Nasdaq
- Market Cap
- SFWL 74.2M
- ANIX 84.7M
- IPO Year
- SFWL 2023
- ANIX 1987
- Fundamental
- Price
- SFWL $1.01
- ANIX $2.89
- Analyst Decision
- SFWL
- ANIX Strong Buy
- Analyst Count
- SFWL 0
- ANIX 3
- Target Price
- SFWL N/A
- ANIX $9.00
- AVG Volume (30 Days)
- SFWL 10.3K
- ANIX 54.5K
- Earning Date
- SFWL 06-10-2025
- ANIX 06-10-2025
- Dividend Yield
- SFWL N/A
- ANIX N/A
- EPS Growth
- SFWL 4.79
- ANIX N/A
- EPS
- SFWL 0.13
- ANIX N/A
- Revenue
- SFWL $504,158,000.00
- ANIX N/A
- Revenue This Year
- SFWL N/A
- ANIX N/A
- Revenue Next Year
- SFWL N/A
- ANIX N/A
- P/E Ratio
- SFWL $7.72
- ANIX N/A
- Revenue Growth
- SFWL 24.75
- ANIX N/A
- 52 Week Low
- SFWL $0.81
- ANIX $2.07
- 52 Week High
- SFWL $2.15
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- SFWL 52.77
- ANIX 61.99
- Support Level
- SFWL $0.94
- ANIX $2.50
- Resistance Level
- SFWL $1.02
- ANIX $2.72
- Average True Range (ATR)
- SFWL 0.05
- ANIX 0.16
- MACD
- SFWL -0.00
- ANIX 0.02
- Stochastic Oscillator
- SFWL 62.50
- ANIX 72.88
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.